Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease
© Grund et al.; licensee BioMed Central Ltd. 2014
Received: 19 June 2014
Accepted: 27 September 2014
Published: 8 October 2014
Protection against infection by Newcastle disease virus (NDV), also designated as avian paramyxovirus subtype-1 (APMV-1), is mediated by immune responses to the two surface glycoproteins, hemagglutinin-neuraminidase (HN) and fusion (F) protein. Thus, a chimeric APMV-1 based vaccine that encodes APMV-8 HN- and F-proteins and expresses the hemagglutinin of avian influenza virus (AIV) H5N1, is able to protect against HPAIV H5N1 but fails to protect against NDV [PLoS One 8: e72530, 2013]. However, it is unclear whether avirulent APMV-subtypes, like APMV-8 can induce subtype-specific immunity and protect from a homologous challenge.
APMV-8 infections of 3- and 6-weeks-old specific pathogen free (SPF)-chickens did not induce any clinical signs but was associated with virus shedding for up to 6 days. Viral replication was only detected in oropharyngeal- and never in cloacal swabs. Upon reinfection with homologous APMV-8, viral shedding was restricted to day 2 and in contrast to naive SPF-chickens, only RNA but no infectious virus was recovered. No protection was induced against virulent NDV challenge, although morbidity and mortality was delayed in APMV-8 primed chickens. This lack of protection is in line with a lack of reactivity of APMV-8 specific sera to APMV-1 HN-protein: Neither by hemagglutin-inhibition (HI) test nor immunoblot analyses, cross-reactivity was detected, despite reactivity to internal proteins.
Immune responses mounted during asymptomatic APMV-8 infection limit secondary infection against homologues reinfection and facilitates a delay in the onset of disease in a subtype independent manner but is unable to protect against Newcastle disease, a heterologous APMV-subtype.
KeywordsAPMV-8 APMV NDV Newcastle disease Cross-reactivity Cross-protection
Avian paramyxoviruses (APMV) replicate within the respiratory tract and intestine of their natural avian host. They belong to the genus Avulavirus in the family Paramyxoviridae within the order Mononegavirales. Currently, 12 subtypes have been identified with APMV-1 to -9 known as ‘classical strains’ and APMV-10 to 12 recently described[3–5]. The prototypic virus, APMV-1 or Newcastle Disease virus (NDV) causes a devastating disease in poultry and represents a major threat for poultry production in the world. In contrast, the other APMV-subtypes are not clinically relevant for poultry and circulate largely unnoticed in wild birds. Also for APMV-1, strains of low virulence are well known. They do not induce clinical signs in immune competent birds but confer protection against ND[7–9]. The generation of recombinant NDV (rNDV) containing specific alterations in the genome decreased residual virulence and were also used as vector system to express genes of other pathogens, e.g. highly pathogenic avian influenza virus (HPAIV)[11, 12]. To avoid interference by maternal NDV antibodies with vaccine vector performance, we created a chimeric virus (ch NDVFHN PMV8H5) by substituting the envelope glycoproteins hemagglutinin-neuraminidase (HN) and fusion protein (F) of NDV by those of APMV-8 and expressing H5 of HPAIV. APMV-8 was chosen as donor of HN and F because of its apathogenicity for poultry, description of only weak cross-reactivity between APMV-1 and APMV-8[15, 16] and low prevalence[17–19]. Vaccination with this chimeric vector HPAIV-H5-vaccine resulted in efficient protection against HPAIV H5N1 infection in chickens with NDV specific maternal antibodies (MDA). However, evasion from maternal NDV antibodies was accompanied by a lack of protection against ND. This observation corresponds to investigations by Nayak et al. describing absence of protection against NDV challenge after APMV-8 infection. The serological data of the vaccination experiments with ch NDVFHN PMV8H5 as well as the APMV-8 infection suggested that APMV-8 glycoproteins were immunogenic in the host. However, it remained unclear whether an APMV-8 immune response was sufficient to induce protection against homologous APMV-8 challenge. Here we describe a set of animal experiments demonstrating, that APMV-8 infection does not prevent subsequent reinfection with homologous APMV-8 but limits viral shedding.
Materials and methods
Chickens from SPF-eggs (LAH, Cuxhaven), hatched at the FLI were infected oculo-nasally at 3 weeks of age with 0.1 ml of APMV-8/goose/Delaware/1053/76 containing 106 TCID50 (n = 18). Two days post infection (dpi) two naive chickens were introduced as sentinel birds. On each of day 2, 4, 6 and 21 dpi two inoculated chickens were sacrificed and indicated internal organs were tested for APMV-8 by RT-qPCR (primer probe sequence see Additional file1: Table S1). Three weeks after initial infection, groups were divided, one being challenged oculo-nasally with NDV/Herts33/56 (106 EID50/animal) and the other re-infected oculo-nasally with APMV-8/goose/Delaware/1053/76 (106 TCID50/animal). In addition, each of the two viruses at the same dose and route was administered to 6 naive chickens from the same hatch. Animals were scored daily according their clinical condition (0 = healthy; 1 = sick; 2 = dead) and clinical index was calculated analogous to determining intracerebral pathogenicity index (ICPI). At indicated time intervals post infection either oropharyngeal and cloacal swabs (primary infection) or combined oropharyngeal and cloacal swabs were taken for virus detection. Heparinised blood samples were obtained from all animals before vaccination, before challenge- or reinfection as well as from all surviving birds at the end of the observation period, and were tested for NDV- and APMV-8-specific antibodies using the hemagglutination inhibition (HI) assay. All animal experiments were carried out in BSL3 experimental animal facilities and had been approved by the animal welfare committee (LALLF M-V/TSD/7221.3-1.1-053/10). See Additional file for specification of viruses (Additional file2: Table S2) and APMV-subtype specific sera with their degree of cross-reactivity (Additional file3: Table S3).
Results and discussion
Three weeks after the initial experiment, five APMV-8 infected chickens and one sentinel animal, now six weeks old, were reinfected with 106 TCID50 of homologous APMV-8 strain. In addition, a group of six chickens from the same hatch but kept separately, were APMV-8 infected. As anticipated, birds inoculated with APMV-8 did not develop clinical signs but virus shedding was detected in naive 6-weeks-old chickens from day 2 pi by RT-qPCR as well as by virus isolation comparable to shedding observed before in the 3-weeks-old animals. In contrast, in animals with previous exposure to APMV-8, virus was only detected in 3 out of 6 (47, 89 and 12087 infectivity equivalents/ml) inoculated chickens on day 2 pi and only by RT-qPCR (Figure 3). The chickens that served as sentinel for the first infection remained virus negative in all tested samples. After APMV-8 reinfection, a slight increase in antibody titer was observed, supporting the notion of limited virus-replication. It is interesting to note, that age of the animal has apparently little effect on virus replication, since virus shedding (Figure 3, A and B) and antibody response (Figure 1, A and B control) in 3- and 6-weeks-old chickens were comparable.
Active local replication of APMV-8 induced an immune response efficacious to limit APMV-8 reinfection but unable to protect against heterologous APMV-1 subtype.
We like to thank Cornelia Illing for excellent technical assistance, Dr. Mario Ziller for sophisticated statistical analysis and our colleagues from the animal core facility (ATB) for diligent taking care of the animals.
- Wang LF, Collins PL, Fouchier RAM, Kurath G, Lamb RA, Randall RE, Rima BK: Paramyxoviridea. In Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. Edited by: King AMQ, Adams MJ, Carstens EB, Lewkowitz EJ. London: Elsevier; 2012:672-685.Google Scholar
- Alexander DJ: Newcastle disease and other avian paramyxoviruses. Rev Sci Tech 2000, 19: 443-462.PubMedGoogle Scholar
- Briand FX, Henry A, Massin P, Jestin V: Complete genome sequence of a novel avian paramyxovirus. J Virol 2012, 86: 7710. 10.1128/JVI.00946-12PubMedPubMed CentralView ArticleGoogle Scholar
- Miller PJ, Afonso CL, Spackman E, Scott MA, Pedersen JC, Senne DA, Brown JD, Fuller CM, Uhart MM, Karesh WB, Brown IH, Alexander DJ, Swayne DE: Evidence for a new avian paramyxovirus serotype 10 detected in rockhopper penguins from the Falkland Islands. J Virol 2010, 84: 11496-11504. 10.1128/JVI.00822-10PubMedPubMed CentralView ArticleGoogle Scholar
- Terregino C, Aldous EW, Heidari A, Fuller CM, De Nardi R, Manvell RJ, Beato MS, Shell WM, Monne I, Brown IH, Alexander DJ, Capua I: Antigenic and genetic analyses of isolate APMV/wigeon/Italy/3920-1/2005 indicate that it represents a new avian paramyxovirus (APMV-12). Arch Virol 2013, 158: 2233-2243. 10.1007/s00705-013-1735-2PubMedView ArticleGoogle Scholar
- Alexander DJ: Newcastle disease and other avian Paramyxoviridae infections. Diseases of poultry. 10th edition. Edited by: Calnek BW. Ames: (Mosby-Wolfe iowa State University Press; 1997:541-569.Google Scholar
- Goldhaft TM: Historical note on the origin of the LaSota strain of Newcastle disease virus. Avian Dis 1980, 24: 297-301. 10.2307/1589696PubMedView ArticleGoogle Scholar
- Hanson RP, Brandly CA: Identification of vaccine strains of Newcastle disease virus. Science 1955, 122: 156-157.PubMedGoogle Scholar
- Hitchner SB: Serendipity in science-discovery of the B-1 strain of Newcastle Disease virus. Avian Dis 1975, 19: 215-223. 10.2307/1588975PubMedView ArticleGoogle Scholar
- Ramp K, Topfstedt E, Wäckerlin R, Höper D, Ziller M, Mettenleiter TC, Grund C, Römer-Oberdörfer A: Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination. Avian Dis 2012, 56: 208-217. 10.1637/9870-080311-Reg.1PubMedView ArticleGoogle Scholar
- Schröer D, Veits J, Grund C, Dauber M, Keil G, Granzow H, Mettenleiter TC, Römer-Oberdörfer A: Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus. Avian Dis 2009, 53: 190-197. 10.1637/8416-072308-Reg.1PubMedView ArticleGoogle Scholar
- Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, Starick E, Mundt E, Schirrmeier H, Mebatsion T, Mettenleiter TC, Römer-Oberdörfer A: Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci USA 2006, 103: 8197-8202. 10.1073/pnas.0602461103PubMedPubMed CentralView ArticleGoogle Scholar
- Steglich C, Grund C, Ramp K, Breithaupt A, Höper D, Keil G, Veits J, Ziller M, Granzow H, Mettenleiter TC, Römer-Oberdörfer A: Chimeric Newcastle Disease Virus Protects Chickens against Avian Influenza in the Presence of Maternally Derived NDV Immunity. PLoS One 2013, 8: e72530. 10.1371/journal.pone.0072530PubMedPubMed CentralView ArticleGoogle Scholar
- Kim SH, Xiao S, Shive H, Collins PL, Samal SK: Replication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1–9 in chickens and ducks. PLoS One 2012, 7: e34927. 10.1371/journal.pone.0034927PubMedPubMed CentralView ArticleGoogle Scholar
- Cloud SS, Rosenberger JK: Characterization of nine avian paramyxoviruses. Avian Dis 1980, 24: 139-152. 10.2307/1589773View ArticleGoogle Scholar
- Lipkind M, Shihmanter E: Antigenic relationships between avian paramyxoviruses. I. Quantitative characteristics based on hemagglutination and neuraminidase inhibition tests. Arch Virol 1986, 89: 89-111. 10.1007/BF01309882PubMedView ArticleGoogle Scholar
- Dormitorio TV, Giambrone JJ, Guo K, Hepp GR: Detection and characterization of avian influenza and other avian paramyxoviruses from wild waterfowl in parts of the southeastern United States. Poult Sci 2009, 88: 851-855. 10.3382/ps.2008-00337PubMedView ArticleGoogle Scholar
- Goekjian VH, Smith JT, Howell DL, Senne DA, Swayne DE, Stallknecht DE: Avian influenza viruses and avian paramyxoviruses in wintering and breeding waterfowl populations in North Carolina, USA. J Wildl Dis 2011, 47: 240-245. 10.7589/0090-3558-47.1.240PubMedView ArticleGoogle Scholar
- Umali DV, Ito H, Katoh H, Ito T: Surveillance of Avian Paramyxovirus in Migratory Waterfowls in the San-in Region of Western Japan from 2006 to 2012. J Vet Med Sci 2014, 76: 423-430. 10.1292/jvms.13-0539PubMedPubMed CentralView ArticleGoogle Scholar
- Nayak B, Dias FM, Kumar S, Paldurai A, Collins PL, Samal SK: Avian paramyxovirus serotypes 2–9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1). Vaccine 2012, 30: 2220-2227. 10.1016/j.vaccine.2011.12.090PubMedPubMed CentralView ArticleGoogle Scholar
- CEC: Council Directive 92/66/EEC introducing Community measures for the control of Newcastle disease. Official Journal of the European Community L 1992, 260: 1-20.Google Scholar
- Steglich C, Grund C, Röder A, Zhao N, Mettenleiter TC, Römer-Oberdörfer A: Chimeric avian paramyxovirus-based vector immunization against highly pathogenic avian influenza followed by conventional Newcastle disease vaccination eliminates lack of protection from virulent ND virus. Trials Vaccinol 2014, 3: 65-72.View ArticleGoogle Scholar
- Development Core Team: R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011. URL:http://www.r-project.org/Google Scholar
- Häuslaigner R, Sonnenburg J, Kothlow S, Kaspers B, Staubach C, Grund C: Evaluation of an indirect enzyme-linked immunosorbent assay to study the specific humoral immune response of Muscovy ducks (Cairina moschata) and domestic geese (Anser anser var. domestica) after vaccination against Newcastle disease virus. Avian Pathol 2009, 38: 89-95. 10.1080/03079450902737813PubMedView ArticleGoogle Scholar
- Paldurai A, Subbiah M, Kumar S, Collins PL, Samal SK: Complete genome sequences of avian paramyxovirus type 8 strains goose/Delaware/1053/76 and pintail/Wakuya/20/78. Virus Res 2009, 142: 144-153. 10.1016/j.virusres.2009.02.003PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.